OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy, et al.
Cell Metabolism (2020) Vol. 31, Iss. 3, pp. 605-622.e10
Open Access | Times Cited: 100
Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy, et al.
Cell Metabolism (2020) Vol. 31, Iss. 3, pp. 605-622.e10
Open Access | Times Cited: 100
Showing 1-25 of 100 citing articles:
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Audrey Deprince, Joel T. Haas, Bart Staels
Molecular Metabolism (2020) Vol. 42, pp. 101092-101092
Open Access | Times Cited: 360
Audrey Deprince, Joel T. Haas, Bart Staels
Molecular Metabolism (2020) Vol. 42, pp. 101092-101092
Open Access | Times Cited: 360
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia‐Sancho, Esther Caparrós, Anabel Fernández‐Iglesias, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 411-431
Closed Access | Times Cited: 249
Jordi Gracia‐Sancho, Esther Caparrós, Anabel Fernández‐Iglesias, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 411-431
Closed Access | Times Cited: 249
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 113
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 113
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
Francesco De Chiara, Karen Louise Thomsen, Abeba Habtesion, et al.
Hepatology (2019) Vol. 71, Iss. 3, pp. 874-892
Open Access | Times Cited: 78
Francesco De Chiara, Karen Louise Thomsen, Abeba Habtesion, et al.
Hepatology (2019) Vol. 71, Iss. 3, pp. 874-892
Open Access | Times Cited: 78
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong, Dongjie Li, Hongbo Meng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3650-3666
Open Access | Times Cited: 63
Jie Tong, Dongjie Li, Hongbo Meng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3650-3666
Open Access | Times Cited: 63
Lipid Metabolism and Cancer
Hui Cheng, Meng Wang, Jingjing Su, et al.
Life (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 62
Hui Cheng, Meng Wang, Jingjing Su, et al.
Life (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 62
The Liver–α-Cell Axis in Health and in Disease
Michael M. Richter, Katrine D. Galsgaard, Emilie Elmelund, et al.
Diabetes (2022) Vol. 71, Iss. 9, pp. 1852-1861
Open Access | Times Cited: 53
Michael M. Richter, Katrine D. Galsgaard, Emilie Elmelund, et al.
Diabetes (2022) Vol. 71, Iss. 9, pp. 1852-1861
Open Access | Times Cited: 53
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 38
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 38
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Pengxiang Qu, Oren Rom, Ke Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 742-757.e10
Open Access | Times Cited: 36
Pengxiang Qu, Oren Rom, Ke Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 742-757.e10
Open Access | Times Cited: 36
Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 23
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 23
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Alexandra C Finney, Sandeep R. Das, Dhananjay Kumar, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Alexandra C Finney, Sandeep R. Das, Dhananjay Kumar, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice
Xin Wang, Yufeng Jin, Can Di, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
Xin Wang, Yufeng Jin, Can Di, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
Reduced adipocyte glutaminase activity promotes energy expenditure and metabolic health
Simon Lecoutre, Salwan Maqdasy, David Rizo‐Roca, et al.
Nature Metabolism (2024)
Open Access | Times Cited: 7
Simon Lecoutre, Salwan Maqdasy, David Rizo‐Roca, et al.
Nature Metabolism (2024)
Open Access | Times Cited: 7
Recent Updates on Obesity Treatments: Available Drugs and Future Directions
Nathalia Romanelli Vicente Dragano, Johan Fernø, Carlos Diéguez, et al.
Neuroscience (2020) Vol. 437, pp. 215-239
Closed Access | Times Cited: 58
Nathalia Romanelli Vicente Dragano, Johan Fernø, Carlos Diéguez, et al.
Neuroscience (2020) Vol. 437, pp. 215-239
Closed Access | Times Cited: 58
Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
Huige Lin, Lin Wang, Zhuohao Liu, et al.
Advanced Science (2022) Vol. 9, Iss. 20
Open Access | Times Cited: 28
Huige Lin, Lin Wang, Zhuohao Liu, et al.
Advanced Science (2022) Vol. 9, Iss. 20
Open Access | Times Cited: 28
Spatial metabolomics and its application in the liver
André A. Santos, Teresa C. Delgado, Vanda Marques, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1158-1179
Open Access | Times Cited: 20
André A. Santos, Teresa C. Delgado, Vanda Marques, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1158-1179
Open Access | Times Cited: 20
Alleviation of Photoreceptor Degeneration Based on Fullerenols in rd1 Mice by Reversing Mitochondrial Dysfunction via Modulation of Mitochondrial DNA Transcription and Leakage
Junling Yang, Xia Chen, A Luodan, et al.
Small (2023) Vol. 19, Iss. 44
Closed Access | Times Cited: 16
Junling Yang, Xia Chen, A Luodan, et al.
Small (2023) Vol. 19, Iss. 44
Closed Access | Times Cited: 16
The cuproptosis-related gene glutaminase promotes alveolar macrophage copper ion accumulation in chronic obstructive pulmonary disease
Linxiao Han, Wensi Zhu, Hui Qi, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111585-111585
Closed Access | Times Cited: 6
Linxiao Han, Wensi Zhu, Hui Qi, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111585-111585
Closed Access | Times Cited: 6
Myokines: metabolic regulation in obesity and type 2 diabetes
Zhi-Tian Chen, Zhi-Xuan Weng, Jiandie D. Lin, et al.
Life Metabolism (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 6
Zhi-Tian Chen, Zhi-Xuan Weng, Jiandie D. Lin, et al.
Life Metabolism (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 6
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 6
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 6
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis
María Mercado-Gómez, Naroa Goikoetxea‐Usandizaga, Annarein Kerbert, et al.
Metabolism (2024) Vol. 158, pp. 155952-155952
Closed Access | Times Cited: 6
María Mercado-Gómez, Naroa Goikoetxea‐Usandizaga, Annarein Kerbert, et al.
Metabolism (2024) Vol. 158, pp. 155952-155952
Closed Access | Times Cited: 6
Essentiality of SLC7A11-mediated nonessential amino acids in MASLD
Jie Shen, Enjun Xie, Shuying Shen, et al.
Science Bulletin (2024)
Open Access | Times Cited: 6
Jie Shen, Enjun Xie, Shuying Shen, et al.
Science Bulletin (2024)
Open Access | Times Cited: 6
A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease
Qingxia Huang, S. U. Qadri, Hua Bian, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 5
Qingxia Huang, S. U. Qadri, Hua Bian, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 5
Sono-mediated glutamine metabolic nanoplatform against liver fibrosis via breaking the vicious self-injury of activated hepatic stellate cells
Peng Yang, Weijing Liu, Zhuang Chen, et al.
Nano Today (2025) Vol. 61, pp. 102641-102641
Closed Access
Peng Yang, Weijing Liu, Zhuang Chen, et al.
Nano Today (2025) Vol. 61, pp. 102641-102641
Closed Access
